CSR Activities Related to the Society SocIETy Basic Policy Material CSR Issues Review of Fiscal 2013 Initiatives Activities to be Tackled in Fiscal 2014 Astellas Pharma Inc.  _ Annual Report 2014 62 Astellas is working to enhance the sustainability of the society through its social contribution activities, including  providing support to local communities and the advancement of medicine. We are also leveraging partnerships with  a range of stakeholders in an effort to solve social issues which affect people throughout the world. Astellas will work to improve measures and provide disclosure of information with respect to social contribution  activities such as donations, community contribution, and support for patients associations. In addition, Astellas will  explore measures and leverage its strengths and technologies in addressing global social issues where it can contrib- ute as a pharmaceuticals company, including the Post-2015 Development Agenda. • Implemented skills development training for research fellows from developing countries • Supported research that contributes to the advancement of medicine • Implemented “Changing Tomorrow Day” activities, an initiative for employees to participate in volunteer work • Pursued patient assistance and advocacy activities • Decided to support “Action on Fistula” program for treating obstetric fistula in Kenya (May 2014) • Developed an oral dispersible pediatric formulation of praziquantel for schistosomiasis. • Promoted joint drug discovery research on neglected tropical diseases (NTDs). Developed the world's first  integrated NTDs drug discovery database called iNTRODB. Improvement of healthcare infrastructure and service  to solve Access to Health issues Patient assistance and advocacy Philanthropic community contribution Societal benefit-driven product development Advancement of medical science